Onderneming Kiniksa Pharmaceuticals, Ltd.
Aandelen
KNSA
BMG5269C1010
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
17,88 USD | +1,53% | +5,74% | +1,94% |
23/04 | Kiniksa Pharmaceuticals Q1 Verlies neemt toe, omzet stijgt | MT |
23/04 | Transcript : Kiniksa Pharmaceuticals, Ltd., Q1 2024 Earnings Call, Apr 23, 2024 |
Vakgebied
Aantal werknemers: 297
Verkoop per activiteit
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Therapeutic Medicines
100,0
%
| 220 | 100,0 % | 270 | 100,0 % | +22,74% |
Verkoop per regio
USD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Bermuda
100,0
%
| 220 | 100,0 % | 270 | 100,0 % | +22,74% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Eben Tessari
FOU | Founder | 42 | 01-07-15 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 01-07-15 |
Mark Ragosa
DFI | Director of Finance/CFO | 50 | 01-05-18 |
Chad Morin
CMP | Compliance Officer | - | 01-10-20 |
John Paolini
CTO | Chief Tech/Sci/R&D Officer | 59 | 01-08-16 |
Rachel Frank
IRC | Investor Relations Contact | - | - |
General Counsel | - | 01-08-20 | |
Ross Moat
PRN | Corporate Officer/Principal | 43 | 01-01-19 |
Martina Struck
LAW | General Counsel | - | 01-01-18 |
Melissa Manno
HRO | Human Resources Officer | - | 01-01-17 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Felix Baker
BRD | Director/Board Member | 55 | 01-10-15 |
Barry D. Quart
BRD | Director/Board Member | 67 | 01-10-15 |
Thomas Malley
BRD | Director/Board Member | 55 | 01-12-16 |
Richard Levy
BRD | Director/Board Member | 66 | 04-03-19 |
Kim Popovits
BRD | Director/Board Member | 65 | 01-02-18 |
G. Cole
BRD | Director/Board Member | 68 | 27-07-20 |
Stephen Biggar
BRD | Director/Board Member | 53 | 01-10-15 |
Sanj Patel
CEO | Chief Executive Officer | 54 | 01-07-15 |
Tracey McCain
BRD | Director/Board Member | 56 | 01-02-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 16 057 618 | 0 | 0 | 54,58 % |
Aandeel B | 1 | 12 781 964 | 0 | 0 | |
Aandeel C | 1 | 1 795 158 | 0 | 0 | |
Aandeel D | 1 | 40 305 405 | 38 720 038 ( 96,07 %) | 0 |
Bedrijfsgegevens
Sector
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+1,94% | 1,27 mld. | |
-2,31% | 103 mld. | |
+0,56% | 95,28 mld. | |
+1,69% | 22,15 mld. | |
-17,37% | 21,02 mld. | |
-9,30% | 18,15 mld. | |
-41,01% | 16,73 mld. | |
-14,85% | 16,05 mld. | |
+3,21% | 13,68 mld. | |
+33,54% | 12,17 mld. |
- Beurs
- Aandelen
- Koers KNSA
- Onderneming Kiniksa Pharmaceuticals, Ltd.